Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
METHYLENE BLUE FOR TREATMENT OF HOSPITALIZED COVID-19 PATIENTS: A RANDOMIZED, CONTROLLED, OPEN-LABEL CLINICAL TRIAL, PHASE 2.
Hamidi-Alamdari D, Hafizi-Lotfabadi S, Bagheri-Moghaddam A, Safari H, Mozdourian M, Javidarabshahi Z, Peivandi-Yazdi A, Ali-Zeraati A, Sedaghat A, Poursadegh F, Barazandeh-Ahmadabadi F, Agheli-Rad M, Tavousi SM, Vojouhi S, Amini S, Amini M, Majid-Hosseini S, Tavanaee-Sani A, Ghiabi A, Nabavi-Mahalli S, Morovatdar N, Rajabi O, Koliakos G. Hamidi-Alamdari D, et al. Among authors: sedaghat a. Rev Invest Clin. 2021;73(3):190-198. doi: 10.24875/RIC.21000028. Rev Invest Clin. 2021. PMID: 34019535 Free article. Clinical Trial.
Effects of propolis and melatonin on oxidative stress, inflammation, and clinical status in patients with primary sepsis: Study protocol and review on previous studies.
Pahlavani N, Sedaghat A, Bagheri Moghaddam A, Mazloumi Kiapey SS, Gholizadeh Navashenaq J, Jarahi L, Reazvani R, Norouzy A, Nematy M, Safarian M, Ghayour-Mobarhan M. Pahlavani N, et al. Among authors: sedaghat a. Clin Nutr ESPEN. 2019 Oct;33:125-131. doi: 10.1016/j.clnesp.2019.06.007. Epub 2019 Jul 5. Clin Nutr ESPEN. 2019. PMID: 31451248 Clinical Trial.
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran.
Abrishami M, Tohidinezhad F, Daneshvar R, Omidtabrizi A, Amini M, Sedaghat A, Amini S, Reihani H, Allahyari A, Seddigh-Shamsi M, Tayyebi M, Naderi H, Bojdy A, Khodashahi R, Eslami S. Abrishami M, et al. Among authors: sedaghat a. Ocul Immunol Inflamm. 2020 Jul 3;28(5):739-744. doi: 10.1080/09273948.2020.1773868. Epub 2020 Jun 22. Ocul Immunol Inflamm. 2020. PMID: 32569494
Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome.
Allahyari A, Seddigh-Shamsi M, Mahmoudi M, Amel Jamehdar S, Amini M, Mozdourian M, Javidarabshahi Z, Eslami Hasan Abadi S, Amini S, Sedaghat A, Emadzadeh M, Moeini Nodeh M, Rahimi H, Bari A, Mozaheb Z, Kamandi M, Ataei Azimi S, Abrishami M, Akbarian A, Ataei P, Allahyari N, Hasanzadeh S, Saeedian N. Allahyari A, et al. Among authors: sedaghat a. Int Immunopharmacol. 2021 Apr;93:107239. doi: 10.1016/j.intimp.2020.107239. Epub 2020 Dec 2. Int Immunopharmacol. 2021. PMID: 33582019 Free PMC article. Clinical Trial.
Comparative effectiveness of pharmacological interventions on mortality and the average length of hospital stay of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
Akbari A, Razmi M, Sedaghat A, Alavi Dana SMM, Amiri M, Halvani AM, Yazdani S, Sahab-Negah S. Akbari A, et al. Among authors: sedaghat a. Expert Rev Anti Infect Ther. 2022 Apr;20(4):585-609. doi: 10.1080/14787210.2022.1997587. Epub 2021 Dec 29. Expert Rev Anti Infect Ther. 2022. PMID: 34694949 Free PMC article.
Effects of Melatonin and Propolis Supplementation on Inflammation, Oxidative Stress, and Clinical Outcomes in Patients with Primary Pneumosepsis: A Randomized Controlled Clinical Trial.
Pahlavani N, Malekahmadi M, Sedaghat A, Rostami A, Alkadir OKA, Taifi A, Ranjbar G, Sahebkar A, Abdelbasset WK, Beigmohammadi MT, Mir M, Bagheri Moghaddam A, Tabesh H, Sadeghi O, Gholizadeh Navashenaq J, Firouzi S, Fathi Najafi M, Safarian M, Ghayour-Mobarhan M. Pahlavani N, et al. Among authors: sedaghat a. Complement Med Res. 2022;29(4):275-285. doi: 10.1159/000523766. Epub 2022 Feb 25. Complement Med Res. 2022. PMID: 35220312 Clinical Trial. English.
The effects of l-Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double-blind, randomized, placebo-controlled trial.
Yahyapoor F, Sedaghat A, Feizi A, Bagherniya M, Pahlavani N, Khadem-Rezaiyan M, Safarian M, Islam MS, Zarifi SH, Arabi SM, Norouzy A. Yahyapoor F, et al. Among authors: sedaghat a. Clin Nutr ESPEN. 2022 Jun;49:61-67. doi: 10.1016/j.clnesp.2022.04.001. Epub 2022 Apr 9. Clin Nutr ESPEN. 2022. PMID: 35623869 Clinical Trial.
Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.
Kaffash Farkhad N, Sedaghat A, Reihani H, Adhami Moghadam A, Bagheri Moghadam A, Khadem Ghaebi N, Khodadoust MA, Ganjali R, Tafreshian AR, Tavakol-Afshari J. Kaffash Farkhad N, et al. Among authors: sedaghat a. Stem Cell Res Ther. 2022 Jun 28;13(1):283. doi: 10.1186/s13287-022-02920-1. Stem Cell Res Ther. 2022. PMID: 35765103 Free PMC article. Clinical Trial.
486 results